Innovative Tech Leadership Sim&Cure leads with cutting-edge digital twin and AI technologies specifically tailored for neurovascular treatments, presenting significant opportunities to collaborate with advanced healthcare institutions seeking to modernize their surgical planning and decision-making tools.

Strong Funding & Growth With recent Series extensions totaling over 20 million euros and an ambitious expansion into Asian markets, Sim&Cure is poised for rapid growth, offering sales prospects for medical device manufacturers, software vendors, and strategic partners aiming to align with a fast-growing medtech innovator.

Strategic Partnerships The company's collaborations with global leaders such as Philips indicate an openness to partnership and licensing opportunities, especially in digital health solutions and integrated neurovascular treatment platforms, opening avenues for co-development and joint marketing initiatives.

Geographic Expansion Sim&Cure's US subsidiary and planned expansion into China and Asia-Pacific regions highlight a target market ripe for scalable neurovascular solutions, creating opportunities to introduce complementary medical products and localized software solutions in these high-growth regions.

Research & Clinical Focus With established collaborations with hospitals and laboratories worldwide, there is a potential to sell complementary clinical support services, customized software modules, or training programs that align with their mission to enhance patient outcomes and clinician experience.